首页> 美国卫生研究院文献>Indian Journal of Clinical Biochemistry >Microalbuminuria in Obese Young and Middle Aged Population: A Potential Marker of Cardiovascular Risk
【2h】

Microalbuminuria in Obese Young and Middle Aged Population: A Potential Marker of Cardiovascular Risk

机译:肥胖青年和中年人群中的微量白蛋白尿:心血管风险的潜在标志

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microalbuminuria is an established cardiovascular risk indicator in diabetes, hypertension and the general population. There is lack of information on MAU in healthy obese Indian adults and an ongoing debate whether obese adults deserve targeted identification and clinical intervention for MAU and prediabetes. We aimed to screen the healthy obese, young (group I) and middle aged (group II) adults for prevalence of MAU and prediabetes and study its association with Framingham risk score. The study included 50 healthy obese young (20–30 years) and middle aged adults (31–50 years), attending the outpatient clinic of Dept. of Medicine for a duration of 2 months (July–August). The patients were screened for fasting blood sugar, lipid profile and MAU. Of the total patients 28 % had MAU, 32.14 % of which had prediabetes and 33.33 % had diabetes whereas 10 % were normoglycemic. The group I patients had 50 % cases of MAU and group II had 25 % patients with MAU. Group II 63.63 % pre-diabetics. The values of MAU obtained were correlated with age, gender, body mass index, systolic and diastolic blood pressure, FBS, waist to hip ratio using Pearson’s Coefficient (p < 0.05). The 10 year CVD risk calculated using FRS in subjects with MAU was higher as compared to those without MAU. Thus we conclude that Indian, young and middle aged obese adults to be at a risk of prediabetes, MAU and CV risk warranting their routine screening for better clinical outcomes.
机译:微量白蛋白尿是糖尿病,高血压和普通人群中已确立的心血管风险指标。在健康肥胖的印度成年人中,有关MAU的信息尚缺乏,并且有关肥胖成年人是否应针对MAU和糖尿病前期进行针对性的鉴定和临床干预的争论仍在不断。我们旨在筛选健康的肥胖,年轻(I组)和中年(II组)成年人的MAU和糖尿病前期患病率,并研究其与Framingham风险评分的关系。该研究包括50名健康肥胖的年轻人(20-30岁)和中年成年人(31-50岁),他们在医学部的门诊就诊,时间为2个月(7月至8月)。筛选患者的空腹血糖,血脂水平和MAU。在全部患者中,有28%的患者患有MAU,其中32.14%的患者患有糖尿病前期,33.33%的患者患有糖尿病,而10%的患者具有正常血糖。 I组患者有50%的MAU患者,II组患者有25%的MAU患者。第二组糖尿病患者占63.63%。使用Pearson系数将获得的MAU值与年龄,性别,体重指数,收缩压和舒张压,FBS,腰臀比相关(p <0.05)。使用FRS计算的MAU受试者的10年CVD风险高于没有MAU的受试者。因此,我们得出结论,印度,年轻和中年肥胖的成年人有患糖尿病前期,MAU和CV的风险,因此有必要对其进行常规筛查以取得更好的临床效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号